TheraSphere™ Y-90 Glass Microspheres: The DOSISPHERE-01 Trial

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

TheraSphere™ Y-90 Glass Microspheres: The DOSISPHERE-01 Trial

By Boston Scientific

190 views

February 17, 2021

The DOSISPHERE-01 Trial is a level I randomized trial that showed advanced HCC patients who ...
read more ↘ receive a personalized TheraSphere dose using multicompartment dosimetry had a median OS of 26.6 months– a 16-month improvement compared to the control arm.
↖ read less

Comments 0